Provogue (India)

Nifty Pharma index rallies 2% in weak market;Ipca, Dr Reddy's gain up to 6%

Stock Market LIVE Updates: Sensex 950 pts lower at 79,200; Nifty at 23,950; IT, Metal, Bank fall 1%

Acme Solar arms commission four SECI projects in Rajasthan

Welspun Specialty Solutions announces change in CFO

Zydus Lifesciences receives USFDA approval for Lidocaine and Prilocaine Cream

This is to inform you that the office of Mr. Hetal Hakani Independent Director of the Company has<BR> come to an end with effect from 13th November 2019 in terms of provisions of section 167(1)(b) of the<BR> Companies Act 2013 due to not attending any Board Meetings held during preceding 12 months.<BR> This information is being disseminated in compliance with provision of regulation 30 of the SEBI<BR> (LODR) Regulation 2015. Kindly take the same on your record and oblige.

This is to inform you that Mr. Vishal Menon Company Secretary of the Company has resigned from his post with effect from the end of business hours of Wednesday the 20th November 2019 and accordingly he ceased to be the Compliance officer and Key Managerial Personnel of the Company with simultaneous effect. The resignation has been accepted and he will be released from all his responsibilities from the closing hours of 20th November 2019.<BR> <BR> This information is being filed in compliance with provision of regulation 30 of the SEBI (LODR) Regulation 2015. Kindly take the same on your record and oblige.

This is to inform you that Mr. Vishal Menon Company Secretary of the Company has resigned from his post with effect from the end of business hours of Wednesday the 20th November 2019 and accordingly he ceased to be the Compliance officer and Key Managerial Personnel of the Company with simultaneous effect. The resignation has been accepted and he will be released from all his responsibilities from the closing hours of 20th November 2019. <BR> <BR> This information is being filed in compliance with provision of regulation 30 of the SEBI (LODR) Regulation 2015. Kindly take the same on your record and oblige.

This is to inform you that pursuant to the applicable provisions of the SEBI (Listing Obligations and<BR> Disclosure Requirements) Regulations 2015 the Liquidator on November 13 2019 has considered and taken on record the un-audited financial results and limited review report for the quarter ended September 30 2019. In view of the same we enclose herewith copies of un-audited financial results along with the limited review reports issued by the Statutory Auditors of the Company thereon.<BR> <BR> The meeting of Directors and Liquidator commenced at 5.00 p.m. and concluded at 9.00 p.m.

This is to inform you that pursuant to the applicable provisions of the SEBI (Listing Obligations and<BR> Disclosure Requirements) Regulations 2015 the Liquidator on November 13 2019 has considered and taken on record the un-audited financial results and limited review report for the quarter ended September 30 2019. In view of the same we enclose herewith copies of un-audited financial results along with the limited review reports issued by the Statutory Auditors of the Company thereon.<BR> <BR> The meeting of Directors and Liquidator commenced at 5.00 p.m. and concluded at 9.00 p.m.<BR>